Josephine Karl, PA
Surgical · Dallas, TXNPI 1316051071
Payments from drug & device makers
Across 919 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$2K
- Sun Pharmaceutical Industries Inc.$2K
- Amgen$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Novartis$977
- plus $8K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 172 | $3,545 |
| Johnson & Johnson | 108 | $2,119 |
| Sun Pharmaceutical Industries Inc. | 69 | $1,651 |
| Amgen | 52 | $1,106 |
| Regeneron Healthcare Solutions, Inc. | 39 | $1,054 |
| Novartis | 47 | $977 |
| UCB, Inc. | 46 | $912 |
| E.r. Squibb & Sons, L.L.C. | 37 | $897 |
| Sanofi | 28 | $813 |
| Pfizer | 62 | $710 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 51 | $708 |
| Incyte Corporation | 34 | $690 |
| Mayne Pharma Commercial LLC | 32 | $607 |
| Dermavant Sciences, Inc. | 31 | $592 |
| LEO Pharma Inc. | 20 | $417 |
| Lilly USA, LLC | 20 | $395 |
| Arcutis Biotherapeutics, Inc. | 19 | $342 |
| Galderma Laboratories, L.p. | 14 | $248 |
| Biofrontera Inc. | 10 | $149 |
| Almirall LLC | 5 | $111 |
| Boehringer Ingelheim | 6 | $105 |
| VYNE Pharmaceuticals Inc. | 5 | $92 |
| Organon | 4 | $64 |
| Journey Medical Corporation | 3 | $52 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $34 |
| Janssen Scientific Affairs, LLC | 1 | $31 |
| Blueprint Medicines Corporation | 1 | $23 |
| Genentech USA, Inc. | 1 | $18 |
How this compares
$18,462 in reported general payments places this provider in the 95th percentile of 804 surgical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical in Dallas
- Lonnie GinnDallas$17K
- Gretchen WilsonDallas$16K
- Jessica GreenemeierDallas$9K
- Kriste HaileDallas$8K
- Erin TenneyDallas$8K
- Brittany BuckmasterDallas$7K
- Bryn BumpasDallas$6K
- Kelly CampbellDallas$5K
- Dallin WoottonDallas$5K
- Alexandria SandersDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.